COVID-19 Survivorship Registry

Recruiting Observational Study
Covid19
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
NYU Langone Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

COVID-19 is associated with acute pulmonary and cardiac injury. To better understand the degree and severity of cardiopulmonary injury as well as short and long-term sequelae of COVID-19 infection, this study will perform longitudinal study in patients who had recent known diagnosis of COVID-19.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * have tested positive for SARS-CoV-2 and discharged from the ICU or, * have tested positive for SARS-CoV-2 and have been discharged from hospital or, * have tested positive for SARS-CoV-2 but was NOT hospitalized * ages 18 and over, and * competent and willing to sign informed …
Contacts

Ashley Witzl

212-263-1208

PASCResearch@nyulangone.org

CONTACT

Daniel Walsh

929-573-0079

Daniel.walsh@nyulangone.org

CONTACT